Insider Selling: CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) Major Shareholder Sells $53,248.60 in Stock

CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) major shareholder Stuart M. Sloan sold 532,486 shares of the business’s stock in a transaction on Wednesday, September 25th. The shares were sold at an average price of $0.10, for a total value of $53,248.60. Following the completion of the sale, the insider now owns 21,067,956 shares in the company, valued at approximately $2,106,795.60. The trade was a 2.47 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

CERo Therapeutics Stock Performance

Shares of CERo Therapeutics stock opened at $0.22 on Friday. CERo Therapeutics Holdings, Inc. has a 52-week low of $0.06 and a 52-week high of $12.80. The stock’s 50-day simple moving average is $0.12 and its 200 day simple moving average is $0.32.

CERo Therapeutics Company Profile

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.